Impact of Admission Glycemic Variability, Glucose, and Glycosylated Hemoglobin on Major Adverse Cardiac Events After Acute Myocardial Infarction
Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 13, 2012
- Accepted September 28, 2012
- Published in print January 23, 2013.
- Published online January 24, 2013.
Article Versions
- You are currently viewing a Previous version of this article (January 24, 2013 - 09:07).
- View the most recent version of this article
Copyright & Usage
© 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
Author Information
- Gong Su, MD, PHD1⇓,
- Shu-hua Mi, MD1⇓,
- Hong Tao, MD, PHD2,
- Zhao Li, MD3,
- Hong-Xia Yang, MD1,
- Hong Zheng, MD1,
- Yun Zhou, MD1 and
- Lei Tian, MD1
- 1Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing, China
- 2Department of Endocrinology, Beijing An Zhen Hospital, Capital Medical University, Beijing, China
- 3Beijing Emergency Center of Heart, Lung and Blood Vessel Diseases, Beijing, China
- Corresponding authors: Gong Su, su_gong{at}yahoo.com, and Shu-hua Mi, mishuhua{at}hotmail.com.
Statistics from Altmetric.com
Article usage
Current Issue
July 2018
Volume 41, Issue 7
Impact of Admission Glycemic Variability, Glucose, and Glycosylated Hemoglobin on Major Adverse Cardiac Events After Acute Myocardial Infarction
